Merck KGaA sees gain in adj EBITDA of up to 18.5 pct

FRANKFURT, May 19 (Reuters) - German drugs and chemicals

maker Merck KGaA expects adjusted core earnings to

increase by up to 18.5 percent this year, helped by additional

profit from a takeover of lab supplies maker Sigma-Aldrich.

Read more